Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Natco Pharma Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Outcome Of Extraordinary General Meeting Held On 29Th November, 2017 And Voting Results
Outcome of Extraordinary General Meeting held on 29th November, 2017 and Voting Results For growth, Natco Pharma to focus on complex drugs, novel delivery systems
Sees advantage in new markets led by Hep C franchise products Natco picks stake in OMRV Hospitals
Natco Pharma has executed definitive agreement and subscribed to 7.50 per cent of the paid-up equity share capital of OMRV Hospitals Pvt Ltd (OMRV) at investment of 7.50 crore. OMRV operates... Natco Pharma invests Rs 7.5 cr in PACE Hospital
Natco Pharma today said it has invested Rs 7.5 crore to pick up 7.5 per cent stake in OMRV Hospitals. NATCO Pharma Ltd would like to announce that today it has executed definitive agreement and... Press Release / Media Release
Natco's investment in OMRV Hospitals Pvt.Ltd.(PACE Hospitals) Natco's partner Alvogen gets nod for influenza drug in US
Natco Pharma's marketing partner Alvogen has received final approval to market oseltamivir phosphate powder used for the treatment of influenza in the US. Alvogen has received final approval and...